| ACE | angiotensin-converting enzyme |
| ACEI | angiotensin-converting enzyme inhibitor |
| ACE2 | angiotensin-converting enzyme 2 |
| ADAM17 | tumor necrosis factor-α-converting enzyme (TACE) |
| Ac-SDKP | N-acetyl-seryl-aspartyl-lysyl-proline |
| Ang 1-7 | angiotensin-(1-7) |
| Ang 1-9 | angiotensin-(1-9) |
| Ang II | angiotensin II; |
| Ang III | angiotensin III |
| Ang IV | angiotensin IV |
| APA | aminopeptidase A |
| APM | aminopeptidase M |
| ARB | angiotensin II type 1 receptor blocker |
| ARDS | acute respiratory distress syndrome |
| AT1R | angiotensin II type 1 receptor |
| AT2R | angiotensin II type 2 receptor |
| C21 | compound 21 |
| COVID-19 | coronavirus disease 2019 |
| DABK | des-Arg9-bradykinin |
| Mas | receptor Mas |
| mACE2 | membrane-bound angiotensin-converting enzyme 2 |
| sACE2 | soluble angiotensin-converting enzyme 2 |
| MrgD | Mas-related G-protein coupled receptor member D |
| RAAS | renin–angiotensin–aldosterone system |
| rhACE2 | recombinant human angiotensin-converting enzyme 2 |
| SARS-CoV | severe acute respiratory syndrome coronavirus |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| TNFα | tumor necrosis factor α |
| TMPRSS2 | transmembrane protease serine 2 |